MedTrace Logo

Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults.

NCT00216450 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2010-04-26

No results posted yet for this study

Summary

The purpose of the study is to confirm the safety and effectiveness of rabeprazole in the treatment of adult patients with Helicobacter pylori (H. pylori) infection in routine clinical practice.

Conditions

Interventions

DRUG

rabeprazole sodium

Sponsors & Collaborators

  • Janssen Cilag Pharmaceutica S.A.C.I., Greece

    lead INDUSTRY

Principal Investigators

  • Janssen-Cilag Pharmaceutica S.A.C.I. Clinical Trial · Janssen-Cilag Pharmaceutica S.A.C.I.

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-10-31
Completion
2006-02-28

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00216450 on ClinicalTrials.gov